Form 4: Delek US Holdings SVP Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Delek US Holdings' SVP & Deputy CFO, Robert G. Wright, sold 7,135 shares of common stock for a weighted average price of $29.24 per share.
Summary
- Robert G. Wright, Senior Vice President and Deputy Chief Financial Officer of Delek US Holdings, Inc. (DK), executed a sale of common stock.
- The transaction involved the disposition of 7,135 shares of Delek US Holdings common stock.
- The shares were sold at a weighted average price of $29.24 per share, with individual sale prices ranging from $29.18 to $29.26.
- Following this transaction, Robert G. Wright beneficially owns 48,294 shares of Delek US Holdings common stock.
- The sale was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan, indicating it was scheduled in advance.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While insider selling can be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns that the sale is based on new, adverse information. It is likely for personal financial planning.
Positives
- The transaction was executed under a Rule 10b5-1(c) plan, which suggests the sale was pre-scheduled and not based on immediate, non-public information, potentially mitigating negative interpretations of insider selling.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces management's direct equity stake in the company.
Future Outlook
This filing is a disclosure of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing reports a routine insider transaction and does not provide specific insights into broader industry trends or competitive landscape. Insider sales are common occurrences across all industries, often for personal financial planning reasons.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure of Trading Plan | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 09/02/2025 | This indicates a pre-scheduled trading plan, which is a common corporate governance practice to allow insiders to sell shares without being accused of trading on material non-public information. |
Stakeholder Impact
- Shareholders may interpret the insider sale as a signal, though the 10b5-1 plan suggests it is for personal liquidity or diversification rather than a negative outlook on the company.
- Regulatory bodies will note the timely and compliant disclosure of the insider transaction.
Key Dates
| Date | Description |
|---|---|
| 09/02/2025 | Date of transaction for the sale of common stock by Robert G. Wright. |
| 09/04/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdA single insider sale, particularly when executed under a Rule 10b5-1 plan, is generally not a strong enough signal to warrant a change in investment recommendation. Such sales are often for personal financial planning, diversification, or liquidity needs. Investors should consider the broader financial health and strategic direction of Delek US Holdings rather than this isolated transaction.
Keywords
Delek US Holdings, DK, Robert G. Wright, Insider Sale, Form 4, SVP, Deputy CFO, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.